Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrasimod in moderate-to-severe atopic dermatitis
NCT04162769Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of etrasimod in atopic dermatitis (AD), sponsored by Arena Pharmaceuticals, Inc.. Started Oct 2019; status: completed.
02
Drugs
etrasimod
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04162769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04162769.